THE REED-STERNBERG CELLS OF HODGKIN DISEASE ARE CLONAL

被引:55
作者
INGHIRAMI, G
MACRI, L
ROSATI, S
ZHU, BY
YEE, HT
KNOWLES, DM
机构
[1] NYU,MED CTR,KAPLAN COMPREHENS CANC CTR,NEW YORK,NY 10016
[2] UNIV TURIN,DEPT BIOMED SCI & HUMAN ONCOL,PATHOL ANAT & HISTOL SECT,TURIN,ITALY
[3] COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,HEMATOPATHOL LAB,NEW YORK,NY 10016
关键词
CLONALITY;
D O I
10.1073/pnas.91.21.9842
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Relatively little progress has been made in understanding the nature of the Reed-Sternberg (RS) cell and its morphologic variants in Hodgkin disease (HD). This is primarily due to the fact that RS cells represent a minute subpopulation within HD lesions. To investigate the clonal origin of RS cells and variants, we studied 27 HD lesions obtained from 11 patients. Using an image analyzer (CAS 200) we were able to demonstrate that CD30-positive RS cells are clonal elements with unique and individualized DNA profiles and that the DNA content of any given patient RS cell population is constant over time and in different pathologic sites. Using 1, 9, 11, and X alpha satellite chromosome probes and interphase cytogenetics, we also demonstrated that RS cells obtained from different tissue samples of the same patient have a unique and often abnormal chromosomal pattern. To definitively prove the hypothesis that CD30-positive RS cells are clonal elements, we investigated the presence of point mutations within p53 gene exons 5 through 9 and found that only a single patient possessed a nonsense p53 somatic point mutation (Arg to His). This same mutation could be identified in all of his available biopsies. Altogether, these findings demonstrate that RS cells and variants in HD are clonal and represent the neoplastic elements of this entity.
引用
收藏
页码:9842 / 9846
页数:5
相关论文
共 20 条
[1]  
ANASTASI J, 1987, AM J PATHOL, V128, P573
[2]   RESTIN - A NOVEL INTERMEDIATE FILAMENT-ASSOCIATED PROTEIN HIGHLY EXPRESSED IN THE REED-STERNBERG CELLS OF HODGKINS-DISEASE [J].
BILBE, G ;
DELABIE, J ;
BRUGGEN, J ;
RICHENER, H ;
ASSELBERGS, FAM ;
CERLETTI, N ;
SORG, C ;
ODINK, K ;
TARCSAY, L ;
WIESENDANGER, W ;
DEWOLFPEETERS, C ;
SHIPMAN, R .
EMBO JOURNAL, 1992, 11 (06) :2103-2113
[3]  
DOGLIONI C, 1991, HEMATOL PATHOL, V5, P67
[4]   P53 MUTATIONS IN HUMAN LYMPHOID MALIGNANCIES - ASSOCIATION WITH BURKITT-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
GAIDANO, G ;
BALLERINI, P ;
GONG, JZ ;
INGHIRAMI, G ;
NERI, A ;
NEWCOMB, EW ;
MAGRATH, IT ;
KNOWLES, DM ;
DALLAFAVERA, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5413-5417
[5]   A CLONED REPEATED DNA-SEQUENCE IN HUMAN-CHROMOSOME HETEROMORPHISMS [J].
GOSDEN, JR ;
LAWRIE, SS ;
COOKE, HJ .
CYTOGENETICS AND CELL GENETICS, 1981, 29 (01) :32-39
[6]   MUTATION OF P53 IN PRIMARY BIOPSY MATERIAL AND CELL-LINES FROM HODGKIN DISEASE [J].
GUPTA, RK ;
PATEL, K ;
BODMER, WF ;
BODMER, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2817-2821
[7]  
HABER MM, 1992, BLOOD, V80, P2851
[8]  
INGHIRAMI G, 1993, LAB INVEST, V68, P746
[9]  
INGHIRAMI G, 1994, J CLIN PATHOL, V16, P16
[10]   PROGNOSTIC VALUE OF DNA PLOIDY AND PROLIFERATIVE ACTIVITY IN HODGKINS-DISEASE [J].
JOENSUU, H ;
KLEMI, PJ ;
KORKEILA, E .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (06) :670-673